129 related articles for article (PubMed ID: 33983375)
21. Clinical characteristics, patterns of lipid-lowering medication use, and health care resource utilization and costs among patients with atherosclerotic cardiovascular disease.
Power TP; Ke X; Zhao Z; Bonine NG; Cziraky MJ; Grabner M; Barron JJ; Quimbo R; Vangerow B; Toth PP
Vasc Health Risk Manag; 2018; 14():23-36. PubMed ID: 29440909
[TBL] [Abstract][Full Text] [Related]
22. Cost and Healthcare Utilization Among Non-Elderly Head and Neck Cancer Patients in the Military Health System, a Single-Payer Universal Health Care Model.
Ambrosio A; Jeffery DD; Hopkins L; Burke HB
Mil Med; 2019 May; 184(5-6):e400-e407. PubMed ID: 30295883
[TBL] [Abstract][Full Text] [Related]
23. Association of Multiple Hospital Affiliations With Clinician Service Use, Breadth of Procedures, and Costs.
Linde S; Beilfuss S
JAMA Netw Open; 2021 Dec; 4(12):e2139169. PubMed ID: 34913978
[TBL] [Abstract][Full Text] [Related]
24. Association of Type of Treatment Facility With Overall Survival After a Diagnosis of Head and Neck Cancer.
Carey RM; Fathy R; Shah RR; Rajasekaran K; Cannady SB; Newman JG; Ibrahim SA; Brant JA
JAMA Netw Open; 2020 Jan; 3(1):e1919697. PubMed ID: 31977060
[TBL] [Abstract][Full Text] [Related]
25. Impact of Cost Display on Ordering Patterns for Hospital Laboratory and Imaging Services.
Silvestri MT; Xu X; Long T; Bongiovanni T; Bernstein SL; Chaudhry SI; Silvestri JI; Stolar M; Greene EJ; Dziura JD; Gross CP; Krumholz HM
J Gen Intern Med; 2018 Aug; 33(8):1268-1275. PubMed ID: 29845468
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of the cost of CA-125 measurement, physical exam, and imaging in the diagnosis of recurrent ovarian cancer.
Armstrong A; Otvos B; Singh S; Debernardo R
Gynecol Oncol; 2013 Dec; 131(3):503-7. PubMed ID: 24060416
[TBL] [Abstract][Full Text] [Related]
27. Surveillance of head neck cancer: Case for personalized and standardized surveillance.
Mali SB
Oral Oncol; 2023 Apr; 139():106354. PubMed ID: 36878144
[TBL] [Abstract][Full Text] [Related]
28. Diagnostic Accuracy of Follow-Up FDG PET or PET/CT in Patients With Head and Neck Cancer After Definitive Treatment: A Systematic Review and Meta-Analysis.
Sheikhbahaei S; Taghipour M; Ahmad R; Fakhry C; Kiess AP; Chung CH; Subramaniam RM
AJR Am J Roentgenol; 2015 Sep; 205(3):629-39. PubMed ID: 26295652
[TBL] [Abstract][Full Text] [Related]
29. Use of CA-125 Tests and Computed Tomographic Scans for Surveillance in Ovarian Cancer.
Esselen KM; Cronin AM; Bixel K; Bookman MA; Burger RA; Cohn DE; Cristea M; Griggs JJ; Levenback CF; Mantia-Smaldone G; Meyer LA; Matulonis UA; Niland JC; Sun C; O'Malley DM; Wright AA
JAMA Oncol; 2016 Nov; 2(11):1427-1433. PubMed ID: 27442965
[TBL] [Abstract][Full Text] [Related]
30. Identification of Baseline Characteristics Associated With Development of Depression Among Patients With Head and Neck Cancer: A Secondary Analysis of a Randomized Clinical Trial.
Panwar A; Rieke K; Burke WJ; Sayles H; Lydiatt WM;
JAMA Otolaryngol Head Neck Surg; 2018 Nov; 144(11):1004-1010. PubMed ID: 30286230
[TBL] [Abstract][Full Text] [Related]
31. Association of Symptoms and Clinical Findings With Anticipated Outcomes in Patients With Recurrent Head and Neck Cancer.
Pipkorn P; Licata J; Kallogjeri D; Piccirillo JF
JAMA Otolaryngol Head Neck Surg; 2018 Aug; 144(8):738-745. PubMed ID: 30003215
[TBL] [Abstract][Full Text] [Related]
32. Intensity-modulated radiation therapy for head-and-neck cancer: the UCSF experience focusing on target volume delineation.
Lee N; Xia P; Fischbein NJ; Akazawa P; Akazawa C; Quivey JM
Int J Radiat Oncol Biol Phys; 2003 Sep; 57(1):49-60. PubMed ID: 12909215
[TBL] [Abstract][Full Text] [Related]
33. Recovering function and surviving treatments are primary motivators for health behavior change in patients with head and neck cancer: Qualitative focus group study.
Henry M; Bdira A; Cherba M; Lambert S; Carnevale FA; MacDonald C; Hier M; Zeitouni A; Kost K; Mlynarek A; Black M; Rosberger Z; Frenkiel S
Palliat Support Care; 2016 Aug; 14(4):364-75. PubMed ID: 26592923
[TBL] [Abstract][Full Text] [Related]
34. Association of NCCN-Recommended Posttreatment Surveillance With Outcomes in Patients With HPV-Associated Oropharyngeal Squamous Cell Carcinoma.
Masroor F; Corpman D; Carpenter DM; Ritterman Weintraub M; Cheung KHN; Wang KH
JAMA Otolaryngol Head Neck Surg; 2019 Oct; 145(10):903-908. PubMed ID: 31393552
[TBL] [Abstract][Full Text] [Related]
35. Association of Disease Recurrence With Survival Outcomes in Patients With Cutaneous Squamous Cell Carcinoma of the Head and Neck Treated With Multimodality Therapy.
Sun L; Chin RI; Gastman B; Thorstad W; Yom SS; Reddy CA; Nussenbaum B; Wang SJ; Knackstedt T; Vidimos AT; Koyfman SA; Manyam BV
JAMA Dermatol; 2019 Apr; 155(4):442-447. PubMed ID: 30810715
[TBL] [Abstract][Full Text] [Related]
36. Post-Treatment Head and Neck Cancer Care: National Audit and Analysis of Current Practice in the United Kingdom.
INTEGRATE (The UK ENT Trainee Research Network)
Clin Otolaryngol; 2021 Jan; 46(1):284-294. PubMed ID: 32734679
[TBL] [Abstract][Full Text] [Related]
37. Clinical Practice Guideline: Evaluation of the Neck Mass in Adults.
Pynnonen MA; Gillespie MB; Roman B; Rosenfeld RM; Tunkel DE; Bontempo L; Brook I; Chick DA; Colandrea M; Finestone SA; Fowler JC; Griffith CC; Henson Z; Levine C; Mehta V; Salama A; Scharpf J; Shatzkes DR; Stern WB; Youngerman JS; Corrigan MD
Otolaryngol Head Neck Surg; 2017 Sep; 157(2_suppl):S1-S30. PubMed ID: 28891406
[TBL] [Abstract][Full Text] [Related]
38. Value of fluoro-2-deoxy-D-glucose-positron emission tomography for detecting metastatic lesions in head and neck cancer.
Fogh SE; Kubicek GJ; Champ C; Intenzo C; Axelrod R; Keane WM; Machtay MM
Am J Clin Oncol; 2012 Aug; 35(4):311-5. PubMed ID: 22772424
[TBL] [Abstract][Full Text] [Related]
39. Posttreatment Imaging in Patients with Head and Neck Cancer without Clinical Evidence of Recurrence: Should Surveillance Imaging Extend Beyond 6 Months?
Gore A; Baugnon K; Beitler J; Saba NF; Patel MR; Wu X; Boyce BJ; Aiken AH
AJNR Am J Neuroradiol; 2020 Jul; 41(7):1238-1244. PubMed ID: 32554418
[TBL] [Abstract][Full Text] [Related]
40. Low-cost oral metronomic chemotherapy versus intravenous cisplatin in patients with recurrent, metastatic, inoperable head and neck carcinoma: an open-label, parallel-group, non-inferiority, randomised, phase 3 trial.
Patil V; Noronha V; Dhumal SB; Joshi A; Menon N; Bhattacharjee A; Kulkarni S; Ankathi SK; Mahajan A; Sable N; Nawale K; Bhelekar A; Mukadam S; Chandrasekharan A; Das S; Vallathol D; D'Souza H; Kumar A; Agrawal A; Khaddar S; Rathnasamy N; Shenoy R; Kashyap L; Rai RK; Abraham G; Saha S; Majumdar S; Karuvandan N; Simha V; Babu V; Elamarthi P; Rajpurohit A; Kumar KAP; Srikanth A; Ravind R; Banavali S; Prabhash K
Lancet Glob Health; 2020 Sep; 8(9):e1213-e1222. PubMed ID: 32827483
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
